Randy Thurman

Ralph H.
Thurman was the founder of VIASYS Healthcare, Inc., founded in 2001, where the titles held included Chairman, President & Chief Executive Officer from 2001 to 2007.
Current jobs include Executive Chairman at ZEST Anchors LLC, Director at Pharmathen SA, Lead Independent Director at Outlook Therapeutics, Inc. starting in 2025, Director at Presbia USA, Inc., and Member at Levitt Equity Partners.
Former jobs include Chairman, President & Chief Executive Officer at SpiroTech; Chairman & Chief Executive Officer at Corning Life Sciences, Inc. from 1993 to 1997; President, Chief Executive Officer & Director at Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1984 to 1993; Chairman & Chief Executive Officer at Strategic Reserves LLC from 1997 to 2001; Chairman at Enzon Pharmaceuticals, Inc. in 2001; Chairman at Orthofix Medical, Inc. from 2013 to 2014; Chairman at CardioNet LLC from 2010 to 2011; Vice Chairman at Arno Therapeutics, Inc. from 2014 to 2015; Executive Chairman at Presbia Holdings LLC from 2013 to 2015; Executive Chairman at Cogent HMG, Inc. from 2012 to 2014; Executive Chairman at Presbia PLC from 2014 to 2017; Director at Bausch Health Americas, Inc.; Director at Ikaria, Inc.; Independent Director at Veradigm, Inc. from 2012 to 2018; Independent Director at TFF Pharmaceuticals, Inc. from 2019 to 2022; Partner at AEA Investors LP in 2014; Senior Advisor at New Mountain Capital LLC; President at Rorer Group, Inc.; and Trustee at Pamplin College of Business.
Education includes undergraduate studies at Virginia Polytechnic Institute & State University, graduate studies at Webster University, and undergraduate studies at Air Command & Staff College.